Since 2012 Adam has been a developer working predominantly with small to medium-sized enterprises. He specialises in delivering extreme value to startups needing to expand online without distracting from their core activities. He is also experienced in software development and digital goods delivery having transitioned several eBooks and mobile-web apps from prototyping to production.
From 2001-2011 Adam was a project manager for the Japanese pharmaceutical company Eisai. He focused on the genetics of Alzheimer's disease, mining the interfaces between human genome project databases and laboratory wet-work. His innovations led to several patent applications. He is the author of the popular science book "3000 Days of Dementia".
Adam holds a PhD from the University of Manchester in the United Kingdom.
If the scope of the work grows, or a client has specialist specs or constraints we can offer partnership with a variety of trusted associates located internationally.